Status:
COMPLETED
Effects of Acupressure on Physiological Indicators, Oxygen Demand and Length of Hospital Stay in Premature Infants With Pulmonary Infiltration
Lead Sponsor:
Changhua Christian Hospital
Conditions:
PreTerm Neonate
Pulmonary Complications
Eligibility:
All Genders
32+ years
Phase:
NA
Brief Summary
In 2020, 11.6% of newborns are delivered prematurely in Taiwan. Excessive sputum is a common symptom of respiratory complications in premature infants. Effective methods for reducing sputum secretion ...
Eligibility Criteria
Inclusion
- Newborn ≤32 weeks of gestational age
- X-ray reporting pulmonary infiltration requiring suctioning
- Treated with O2 nasal cannula or High-flow nasal cannula
Exclusion
- Congenital pulmonary structural abnormalities
- Muscular weakness
- Heart disease, excluding Patent Ductus Arteriosus(PDA) and Atrial Septal Defect (ASD)
- Abnormal bleeding conditions
- Chest tube placement
- Compromised skin integrity at the acupressure sites
Key Trial Info
Start Date :
July 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT07187232
Start Date
July 2 2023
End Date
June 30 2024
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taiwan
Changhua, Taiwan